Nucleic Acid Drugs
Nucleic acid therapeutics, based on nucleic acids or closely related chemical compounds, are an emerging new class of therapeutics for treating unmet medical needs. They are capable of targeting a disease at the genetic level by preventing the expression of disease-causing proteins.
Oncolytic Virus Therapies
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour.
Peptide Drugs
Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains.
Cell Detection and Therapies
Stem Cell Therapies
CAR T-Cell therapies
TCR T-Cell Therapies
CTC Detection
PROTAC Drugs
A proteolysis targeting chimera is a heterobifunctional small molecule composed of two active domains and a linker, capable of removing specific unwanted proteins.
Antibody-drug conjugates (ADCs) are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. Unlike chemotherapy, ADCs are intended to target and kill tumor cells while sparing healthy cells.
ADC Drugs
BD Cooperation
Links:
Shanghai Novopathway Biotechnology
Building No.5, East Huaxia Road No.333, Pudong New Area, Shanghai
BD Cooperation Email: BD@novopathway.com Tel: 021-5838 0618-501
Join Us Email: HR@novopathway.com Tel: 021-5838 0356
Beijing Sun-Novo Pharmaceutical Research
Building No.7, West Shuangying Road No.79 , Changping Area, Beijing
Website: http://www.sun-novo.com
Wechat
BD Cooperation